Why Veru Stock Surged Today | The Motley Fool
The biotech's experimental oral COVID-19 treatment could be a game changer.
Stay updated with breaking news from Mitchell Steiner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The biotech's experimental oral COVID-19 treatment could be a game changer.
12.05.2022 - -FDA States that Veru Should Submit Request for Emergency Use Authorization (EUA) Application Based on Positive Efficacy and Safety Data from the Phase 3 Clinical Study of Sabizabulin in Hospitalized COVID-19 Patients- -IDMC Unanimously Votes to ...
Call End: Veru Inc. (NASDAQ:NASDAQ:VERU) Q2 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Samuel Fisch - Executive Director, Investor Relations and Corporate...
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest...
New drug ‘slashed’ deaths among patients with severe COVID, maker claims